219 related articles for article (PubMed ID: 27203106)
1. Lessons from a Recovering Academic.
Ehlers MD
Cell; 2016 May; 165(5):1043-1048. PubMed ID: 27203106
[TBL] [Abstract][Full Text] [Related]
2. An uncertain future for cardiovascular drug development?
Garber AM
N Engl J Med; 2009 Mar; 360(12):1169-71. PubMed ID: 19297568
[No Abstract] [Full Text] [Related]
3. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
Brewer GJ
J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
[No Abstract] [Full Text] [Related]
4. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
5. Future pharmaceutical research: the need to look beyond science.
Seeger S
Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
[No Abstract] [Full Text] [Related]
6. Organizing for innovation: towards successful translational research.
West W; Nightingale P
Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
[TBL] [Abstract][Full Text] [Related]
7. Industry-sponsored clinical research: a double-edged sword.
Montaner JS; O'Shaughnessy MV; Schechter MT
Lancet; 2001 Dec; 358(9296):1893-5. PubMed ID: 11741648
[TBL] [Abstract][Full Text] [Related]
8. Productivity counts--but the definition is key.
Mervis J
Science; 2005 Jul; 309(5735):726. PubMed ID: 16051784
[No Abstract] [Full Text] [Related]
9. Precompetitive research: a new prescription for drug development?
Woodcock J
Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
[No Abstract] [Full Text] [Related]
10. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
Loregian A; Palù G
Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
[TBL] [Abstract][Full Text] [Related]
11. Learning lessons from drugs that have recently entered the market.
Teague SJ
Drug Discov Today; 2011 May; 16(9-10):398-411. PubMed ID: 21414418
[TBL] [Abstract][Full Text] [Related]
12. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
[TBL] [Abstract][Full Text] [Related]
13. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
Takebe T; Imai R; Ono S
Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
[TBL] [Abstract][Full Text] [Related]
14. Wrong questions, wrong answers? Are we getting the drugs we need?
Lipworth WL; Kerridge IH; Day RO
Clin Pharmacol Ther; 2012 Mar; 91(3):367-9. PubMed ID: 22343808
[No Abstract] [Full Text] [Related]
15. Drug Regulation and Pricing--Can Regulators Influence Affordability?
Eichler HG; Hurts H; Broich K; Rasi G
N Engl J Med; 2016 May; 374(19):1807-9. PubMed ID: 27168431
[No Abstract] [Full Text] [Related]
16. Can China bring its own pipeline to the market?
Louët S
Nat Biotechnol; 2004 Dec; 22(12):1497-9. PubMed ID: 15583646
[No Abstract] [Full Text] [Related]
17. Driving drug discovery: the fundamental role of academic labs.
Silber BM
Sci Transl Med; 2010 May; 2(30):30cm16. PubMed ID: 20445199
[TBL] [Abstract][Full Text] [Related]
18. Aligning pharmaceutical innovation with medical need.
Nathan C
Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
[No Abstract] [Full Text] [Related]
19. Can biochemistry drive drug discovery beyond simple potency measurements?
Chène P
Drug Discov Today; 2012 Apr; 17(7-8):388-95. PubMed ID: 22326379
[TBL] [Abstract][Full Text] [Related]
20. Surviving the blockbuster syndrome.
Service RF
Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
